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Early aldosterone-induced gene product regulates the epithelial
sodium channel by deubiquitylation
Abstract
The mineralocorticoid hormone aldosterone controls sodium reabsorption and BP largely by regulating
the cell-surface expression and function of the epithelial sodium channel (ENaC) in target kidney
tubules. Part of the stimulatory effect of aldosterone on ENaC is mediated by the induction of serum-
and glucocorticoid-regulated kinase 1 (Sgk1), a kinase that interferes with the ubiquitylation of ENaC
by ubiquitin-protein ligase Nedd4-2. In vivo early aldosterone-regulated mRNA now has been identified
in microselected mouse distal nephron by microarray. From 22 mRNA that displayed a two-fold or more
change, 13 were downregulated and nine were upregulated. Besides Sgk1, the induced mRNA include
Grem2 (protein related to DAN and cerebrus [PRDC]), activating transcription factor 3, cAMP
responsive element modulator, and the ubiquitin-specific protease Usp2-45. The induction of this last
enzyme isoform was verified in mouse distal nephron tubule at the protein level. With the use of
Hek293 cells, Xenopus oocytes, and mpkCCD(c14) cells as expression systems, it was shown that
Usp2-45 deubiquitylates ENaC and stimulates ENaC-mediated sodium transport, an effect that is not
additive to that of Sgk1. A deubiquitylating enzyme that targets ENaC in vitro and thus may play a role
in sodium transport regulation was identified within a series of new in vivo early aldosterone-regulated
gene products.
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The mineralocorticoid hormone aldosterone controls sodium reabsorption and BP largely by regulating the cell-surface
expression and function of the epithelial sodium channel (ENaC) in target kidney tubules. Part of the stimulatory effect of
aldosterone on ENaC is mediated by the induction of serum- and glucocorticoid-regulated kinase 1 (Sgk1), a kinase that
interferes with the ubiquitylation of ENaC by ubiquitin-protein ligase Nedd4-2. In vivo early aldosterone-regulated mRNA
now has been identified in microselected mouse distal nephron by microarray. From 22 mRNA that displayed a two-fold or
more change, 13 were downregulated and nine were upregulated. Besides Sgk1, the induced mRNA include Grem2 (protein
related to DAN and cerebrus [PRDC]), activating transcription factor 3, cAMP responsive element modulator, and the
ubiquitin-specific protease Usp2-45. The induction of this last enzyme isoform was verified in mouse distal nephron tubule
at the protein level. With the use of Hek293 cells, Xenopus oocytes, and mpkCCDc14 cells as expression systems, it was shown
that Usp2-45 deubiquitylates ENaC and stimulates ENaC-mediated sodium transport, an effect that is not additive to that of
Sgk1. A deubiquitylating enzyme that targets ENaC in vitro and thus may play a role in sodium transport regulation was
identified within a series of new in vivo early aldosterone-regulated gene products.
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T he stimulatory action of the mineralocorticoid hormonealdosterone on Na reabsorption and K secretion canbe arbitrarily divided in an early regulatory and a late
anabolic phase (1). Early changes in salt transport can be ob-
served within 30 min after initiation of a hormonal treatment
and correspond to short-term regulatory effects that occur dur-
ing circadian fluctuations and at the onset of more drastic
regulatory changes as elicited by restricted salt uptake or loss of
extracellular volume (2,3). These early actions are thought to be
mediated mostly by the induction/repression of proteins that
belong to the regulatory pathways that control the function of
preexisting transport effectors such as the epithelial sodium
channel (ENaC) and the Na,K-ATPase and K channels. As
yet, only a few aldosterone-induced regulatory proteins have
been identified and experimentally shown to have an impact on
ENaC function. These are K-Ras2, identified in amphibian cells,
GILZ, identified in mammalian kidney cells, and the serum and
glucocorticoid-regulated kinase serum- and glucocorticoid-reg-
ulated kinase 1 (Sgk1) that was also shown to be regulated in
mammalian kidney (4–8). Furthermore, the kidney-specific
short form of Wnk1 that stimulates Na reabsorption via the
Na-Cl co-transporter (NCC) was shown to be regulated by
aldosterone in cultured kidney cells (9).
An important mechanism by which Sgk1 stimulates ENaC
cell-surface expression and function is by phosphorylating the
ubiquitin-protein ligase Nedd4-2 and thereby interfering with
its function. Ubiquitylation (i.e., the labeling of target proteins
with ubiquitin polypeptides) of membrane proteins has been
recognized in recent years as an important mechanism for
controlling the cell-surface expression and endosomal/lysoso-
mal degradation of this type of protein (10,11). When Nedd4-2
is not phosphorylated, it can bind to the PY motif in the
COOH-termini of ENaC subunits and ubiquitylate ENaC on
lysine residues that are situated in the NH2 termini, thereby
inducing channel downregulation at the plasma membrane
(12–16). It is interesting that the lack of PY motif in - or
-ENaC that is characteristic of Liddle syndrome, an inherited
form of salt-sensitive hypertension (17–19), leads to an increase
in cell-surface ENaC expression and possibly also to an aug-
mentation in its open probability (Po), causing Na
 retention,
low K, and hypertension (7,20–22). The short signaling cas-
cade that leads from Sgk1 induction via inhibition of Nedd4-2 to
the activation of ENaC represents the first direct link between
the aldosterone-regulated transcriptional activity of the miner-
alocorticoid receptor and the function of ENaC that has been
demonstrated (13).
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The Sgk1–Nedd4-2 pathway, however, cannot be the only
link between aldosterone and ENaC function. This has been
indicated by the results of experiments that were performed
with mpkCCDcl4 cells that expressed Liddle-type ENaC chan-
nels or with mice that expressed an ENaC- subunit with
Liddle mutation, thus displaying impaired ENaC/Nedd4-2 in-
teraction (23,24). In these systems, aldosterone was still able to
stimulate transepithelial sodium transport. Hence, the path-
ways that link the transcriptional activity of activated miner-
alocorticoid receptor to ENaC function independent of ENaC
PY motif and thus presumably independent of Nedd4-2–medi-
ated ubiquitylation still need to be clarified. In that respect, it is
interesting to mention two observations that support the pos-
sibility of an additional aldosterone-induced regulatory mech-
anism that has an impact on ENaC function/surface expres-
sion, namely the demonstration of an unsuspected regulatory
role of -ENaC in collecting duct cells and of a stimulation of
ENaC by Sgk1 that is mediated by the phosphorylation of the 
subunit (25,26). It therefore is anticipated that other gene prod-
ucts are rapidly regulated by aldosterone in target cells that
participate to the control of Na reabsorption and K secretion.
In this study, we describe the comparison by microarray of
RNA that were extracted from epithelial cells of the aldoste-
rone-sensitive distal nephron (ASDN) of control and aldoste-
rone-treated mice. We thereby identified 22 significantly and
more than two-fold regulated RNA. We anticipate that some of
them encode proteins that participate in early regulatory effects
of aldosterone that are independent of ENaC ubiquitylation.
However, in this study, we focused on the induced deubiqui-
tylating enzyme Usp2-45 and demonstrated in expression sys-
tems that it deubiquitylates ENaC and increases its function.
Materials and Methods
Animal studies were in accordance with the Guide for Care and Use
of Laboratory Animals (Institute of Laboratory Animal Resources, Na-
tional Academy of Science, Bethesda, MD).
Mouse Treatment, Kidney Dissection, and Tubule
Microcollection
Female C57BL/6JOlaHsd mice (Harlan, Horst, The Netherlands),
approximately 8 wk of age, received drinking water that contained
0.3% NaCl for at least 5 d before the treatment. All mice were housed
in a temperature- and humidity-controlled room with an automatic
12-h light/dark cycle (6 a.m./6 p.m.). Aldosterone (Acroˆs Organics,
Pittsburgh, PA; 10 g/kg body wt in 0.33% ethanol and 0.9% NaCl) or
canrenoate (Sigma, Sternheim, Germany; 10 mg/kg in 0.9% NaCl) was
injected intraperitoneally, or mice were left untreated. Forty-two min-
utes later, mice were anesthetized with ketamine (Ve´toquinol AG,
Uznach, Switzerland) and xylazine (Streuli AG, Uznach, Switzerland;
intraperitoneally 100 and 0.5 g/g, respectively). They were then per-
fused through the left ventricle with Ringer solution that contained
collagenase and protease (5 and 1 mg in 15 ml, respectively; Sigma)
while the lower vena cava was opened. Kidneys were removed and cut
transversally in 2-mm slices that were incubated for 10 min at 38°C in
a collagenase solution (1 mg/ml Ringer solution). These tubule prep-
arations were then transferred to ice-cold Ringer (1 h after aldosterone
injection), washed, and resuspended three times. Segments (75 to 85) of
cortical collecting duct/connecting tubule (CCD/CNT; approximately
1.1 mm of total length) were identified under a binocular microscope
(SMZ1000; Nikon AG, Egg, Switzerland) at 4°C and transferred directly
into RLT lysis buffer of the Qiagen RNeasy Micro Kit (Qiagen AG,
Hombrechtikon, Switzerland) that contained 1% -mercaptoethanol
(Sigma-Aldrich, Buchs, Switzerland) using a pair of sharp forceps
(F.S.T. GmbH, Heidelberg, Germany). For plasma aldosterone and
corticosterone measurements, mice were anesthetized as described, and
blood was collected by puncture of the vena cava. Plasma aldosterone
and corticosterone levels were measured using an ELISA and a 125I-RIA
kit from Immuno-Biologic Laboratories (Hamburg, Germany), respec-
tively.
RNA Purification and Quality Control, Microarray Target
cRNA Preparation, Target cRNA Hybridization and
GeneChip Scanning, Real-Time Reverse Transcriptase–PCR,
Quality Control of Microarrays, and Statistical Analyses
Please refer to online supplementary materials for detailed methods.
Prediction of Mineralocorticoid Hormone Response Elements
in the Promoter Region of the Mouse Usp2-45 Gene and
Western Blotting of Usp2-45 in Microcollected Mouse
Kidney CNT and CCD
Please refer to online supplementary materials for detailed methods.
Cloning of Mouse Usp2-45, Usp2-69, and Usp15; Site-
Directed Mutagenesis and cRNA Preparation; and
Coexpression of mUsp2-45, Usp2-69, mUsp15, XENaC,
and XSgk in Xenopus laevis Oocytes
Please refer to online supplementary materials for detailed methods.
Two-Electrode Voltage Clamp on Xenopus Oocytes,
Ubiquitylation of ENaC in Hek293 Cells, and Culture and
Retroviral Transduction of mpkCCD Cells
Please refer to online supplementary materials for detailed methods.
Western Blotting and Real-Time PCR of Usp2-45 in
mpkCCDc14 Cells and Transepithelial Electrophysiologic
Measurements
Please refer to online supplementary materials for detailed methods.
Results
Microarray to Identify Early Aldosterone-Regulated mRNA
in Mouse ASDN
To identify other early aldosterone-regulated gene products
in kidney target cells in vivo, we first established a short-term
aldosterone treatment scheme in mice. Female C57BL/6J mice
that received 0.3% NaCl in their water to repress partially their
endogenous aldosterone production were administered an in-
jection at 10:00 a.m. (4 h after beginning of daytime) with
aldosterone (10 g/kg body wt; Figure 1, A and B) or were left
untreated. The aldosterone injection led to a transient increase
in plasma aldosterone that 15 min after injection was at a level
of approximately 10 nM, a value within the range expected for
mice on a low-salt diet (27). The plasma aldosterone concentra-
tion was nearly back to the initial value of approximately 0.5
nM after 60 min.
To obtain kidney aldosterone-target tissue RNA 1 h after
hormone injection, mice were anesthetized 42 min after aldo-
sterone injection and rapidly perfused with collagenase solu-
tion. Kidneys were removed, sliced, and further digested in
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collagenase solution at 38°C for the rest of the hour (in the
absence of aldosterone). The tubule preparation was then trans-
ferred to 4°C, and segments of CNT/CCD were microselected.
The RNA samples that were prepared from single mice were
tested in terms of quantity, integrity, enrichment, contamina-
tion, and response to aldosterone (Figure 1, C and D). These
measurements revealed that in microisolated CNT/CCD seg-
ments, ENaC mRNA was enriched 15- to 40-fold over total
kidney, whereas thick ascending limb–specific triple co-trans-
porter Na,K,Cl co-transporter 2 (NKCC2) mRNA was not
increased. Sgk1 mRNA was enriched three- to four-fold over
the total kidney preparation and specifically further increased
five- to six-fold by aldosterone. It is interesting that the mere
manipulation of the mice increased plasma corticosterone
slightly (Figure 1, A and B) but did not have an impact on Sgk1
expression (Figure 1, C and D). More than two thirds of the
prepared RNA samples fulfilled the selection criteria of quan-
tity, integrity, enrichment, lack of contamination, and Sgk1
induction and could be used as template for cDNA amplifica-
tion and labeled target RNA synthesis. Target cRNA made
from six control and from six aldosterone-injected mice were
separately hybridized to mouse full genome GeneChip mi-
croarrays (MOE 430 v2; Affymetrix, Santa Clara, CA). Raw
array data were processed using the GCRMA and the MAS5
algorithms (Microarray data are available at Array Express
with the accession number E-TABM-229.) The data were fil-
tered using a t test with a cutoff P  0.05 and using a fold-
change limit of 2.0. The cumulative list of genes that fulfilled
these criteria after processing with one of the algorithms com-
prised 90 genes (73 genes with GCRMA and 39 with MAS5). As
detailed in Table 1, 22 genes fulfilled these criteria with both
algorithms, nine that are upregulated and 13 that are down-
regulated. A scatter plot and the hierarchical clustering of the
results that were calculated by the GCRMA method are shown
in Supplementary Figure 1B. We retested the differential ex-
pression level of eight mRNA that were identified in the mi-
croarray screen by real-time RT-PCR (see primers and probes
sequences in the online supplementary material) on RNA from
three other mice per condition. As shown in Table 1, the regu-
lation was verified in six cases.
Aldosterone-Induced Usp2-45 Deubiquitylates ENaC
Ubiquitylation of ENaC had previously been shown to play
an important role in the control of Na reabsorption (12) and
our screening had confirmed that Sgk1, a kinase that is known
to inhibit the action of the ubiquitin-protein ligase Nedd4-2 on
ENaC, was rapidly induced by aldosterone. We focused now
on Usp2, a ubiquitin-specific protease that was also induced
and belongs to a large protein family that is involved in revers-
ing the ubiquitylation of target proteins (28–30). We specifically
investigated the potential role of the isoform Usp2-45 that we
detected in kidney by reverse transcriptase–PCR (RT-PCR),
unlike the other isoform Usp2-69 that is expressed only at low
levels in the kidney (31) (P.F. and F.V., unpublished observa-
tion) and in mpkCCDc14 cell (10-fold difference; discussed fur-
ther). The analysis of the promoter region around the TATA
box of the Usp2-45 isoform identified at least four potential
hormone response elements that support the possibility of a
direct regulation by aldosterone (see Supplementary Figure 2).
An induction by aldosterone of the shorter Usp2-45 isoform but
not of the Usp2-69 isoform was also detected in mpkCCD cells
(discussed further).
To test whether the aldosterone-induced Usp2-45 mRNA
induction translates in vivo into an increase in Usp2-45 protein,
we performed Western blotting of proteins that were prepared
from microselected segments of CNT/CCD that were obtained
from mice that were subjected to the same hormone treatment
as previously performed for the mRNA studies. As shown in
Figure 2, the polyclonal rabbit anti-mouse Usp2-45 antibody
recognized a 45-kD band that was blocked by competing im-
munizing peptide. This band was selectively increased 1 h after
an aldosterone injection by a factor of approximately 2, as
Figure 1. Conditions of short-term aldosterone stimulation. (A)
Time course of plasma aldosterone and corticosterone levels
after intraperitoneal aldosterone injection (10 g/ kg body wt)
at 10 a.m. (means  SEM, n  3 mice per time point). (B)
Comparison of plasma aldosterone (aldo) and corticosterone
(cort) at 10 a.m. and at 10:30 a.m. with or without injection of
vehicle at 10 a.m. (means  SEM, n  3 to 6 mice per point). (C
and D) Test for enrichment and aldosterone stimulation of
RNA prepared from microselected connecting tubule/cortical
collecting duct (CNT/CCD). Mice were administered an injec-
tion of aldosterone as in A or canrenoate or were left untreated,
and RNA was prepared from tubules that were obtained after
1 h. The abundance of  and  epithelial sodium channel
(ENaC), Sgk1 and Na,K,Cl co-transporter 2 (NKCC2)
mRNA was measured by real-time reverse transcriptase–PCR
(RT-PCR) in RNA that was prepared from total kidney (C) and
from microselected tubule segments (D). Given are means rel-
ative to -actin  SEM; n  6 mice. ***P  0.0001 by one-way
ANOVA.
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previously shown for the mRNA. That the Usp2-45 mRNA
indeed encodes an active ubiquitin-specific protease was con-
firmed by the fact that its core domain that is produced in
Escherichia coli very efficiently cleaves ubiquitin off from a test
substrate in vitro (B. Oberfeld et al., unpublished observations)
(32).
To test the possible impact of Usp2-45 on ENaC function, we
coexpressed it with ENaC in Xenopus laevis oocytes and com-
pared the effect of Usp2-45 with that of Sgk1, the kinase that
inhibits endogenous Nedd4-2. Coexpression of Usp2-45 with
ENaC increased the level of amiloride-sensitive Na current
nearly four-fold, an effect similar to that of Sgk1 (Figure 3A and
Supplementary Figure 3, A and B). It is interesting that coex-
pression of Sgk1 with Usp2-45 did not further increase ENaC
function, suggesting that these two enzymes have an impact on
the same regulatory mechanism (Figure 3A and Supplementary
Figure 3B).
To test whether the effect of Usp2-45 was mediated by its
protease activity, we mutated its cysteine 67 that corresponds to
one of the catalytically active amino acids of its cysteine pro-
tease motif (31,33). Consistent with a requirement for an enzy-
matically active Usp2-45, this mutant did not affect ENaC ac-
tivity at the membrane (Figure 3B and Supplementary Figure
3C). To control whether this effect of Usp2-45 was specific for
this ubiquitin-specific protease, we carried out the same exper-
iment with another randomly chosen ubiquitin-specific pro-
tease, Usp15. The results indicated that the effect of Usp2-45 is
specific, because coexpression of Usp15 in contrast rather de-
creased ENaC function (Figure 3C and Supplementary Figure
3D). It is probable that this latter effect is due to the deubiqui-
tylation of other proteins that interfere with the expression of
ENaC. In addition, we coexpressed the longer Usp2-69 isoform
that turned out not to have an impact on ENaC function (Figure
Table 1. Kidney CNT/CCD RNA that changed two-fold or more by 1 h of aldosteronea
RNAb
Affymetrix GeneChip Real-Time RT-PCR
Genebank
Accession
No.
Fold
Changec Range P
Fold
Changed P
Upregulated genes
protein related to DAN and cerberus NM_011825 7.2 2.1 to 17.7 0.045 5.6 0.029
serum/glucocorticoid regulated kinase NM_011361 4.0 3.0 to 5.1 0.0001 8.1 0.001
activating transcription factor 3 BC019946 3.5 2.5 to 4.9 0.001 8.6 0.018
cAMP responsive element modulator NM_013498 3.0 1.3 to 4.5 0.004 1.1 0.651
mus musculus transcribed sequences AI098139 2.9 1.7 to 3.6 0.001
RIKEN cDNA clone 6430570G24 BG069663 2.8 1.7 to 4.4 0.004
ubiquitin specific protease 2 AI553394 2.2 1.2 to 3.8 0.019 1.6 0.001
growth arrest and DNA-damage-inducible 45 gamma AK007410 2.2 1.5 to 3.2 0.001
RIKEN cDNA clone 6430570G24 BG069663 2.2 1.5 to 2.9 0.0001
Downregulated genes
RIKEN cDNA 4833417L20 gene AK017914 0.5 0.3 to 0.9 0.014
imilarity to pir:A45973 (H.sapiens) AI597080 0.5 0.3 to 0.6 0.009
argininosuccinate synthetase 1 BM213298 0.4 0.3 to 0.5 0.007
RIKEN cDNA clone:D630044A17 BB498095 0.4 0.2 to 0.6 0.006
partial mRNA for hypothetical prot. BG817292 0.4 0.3 to 0.6 0.006
fatty acid binding protein 1, liver NM_017399 0.4 0.2 to 0.8 0.006
transcribed sequences BE991175 0.4 0.2 to 0.6 0.006
RIKEN cDNA clone:C230084M03 BM123508 0.4 0.2 to 0.8 0.005
RIKEN cDNA 4833417L20 gene BM217861 0.4 0.3 to 0.4 0.004
H/K-ATPase alpha, nongastric NM_138652 0.4 0.1 to 0.8 0.004 1.0 0.946
Slc22a8 (Oat3) AV330315 0.3 0.1 to 0.6 0.004 0.1 0.024
G0/G1 switch gene 2 NM_008059 0.3 0.2 to 0.6 0.003 0.2 0.015
RIKEN cDNA clone E030031K24 BB533736 0.3 0.2 to 0.5 0.003
aRNA in italics were also tested by real-time reverse transcriptase–PCR.
bRNA with fold-change 2 and t test P  0.05 using GCRMA and MAS5 algorithms.
cValues were obtained using GCRMA.
dReal-time PCR data were obtained with specific intron spanning primer/probe sets, n  3 mice.
Figure 2. Usp2-45 detected by Western blot in CNT/CCD. Al-
dosterone treatment and tubule microselection were as de-
scribed for mRNA preparations. (A) Western blot with rabbit
anti-mouse Usp2-45 antibody with or without immunizing
peptide identifies a 45-kD band that is competed by immuniz-
ing peptide. (B) Representative pair of Western blots from a
control and an aldosterone-treated mouse. The top panels show
the actin band, and the bottom panels show the Usp2-45 band
visualized on the same blots. (C) The Usp2-45 signals were
normalized to the actin signal of the same mouse (n 3 for each
condition), and the means are shown. **P  0.01.
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3D). In this case, we also verified by Western blotting that this
ubiquitin-specific protease isoform was indeed expressed as
expected (Figure 3E).
We then asked whether Usp2-45 interferes with Nedd4-2–
dependent regulation of ENaC, a mechanism that involves the
interaction of Nedd4-2 with PY motifs that are present on the
C-termini of the ENaC subunits and is defective in Liddle
syndrome (14). ENaC that was devoid of PY motifs ( Y673A,
 Y618H,  Y628A) is resistant to Nedd4-2 and thus displayed
a higher level of amiloride-sensitive Na current than did
wild-type ENaC. This current was indeed resistant to the stim-
ulatory action of Usp2-45 (Figure 3F). This observation sup-
ports the hypothesis that Usp2-45 cleaves off ubiquitin moieties
that Nedd4-2 ligates onto ENaC. The involvement of direct
ENaC ubiquitylation was then verified by coexpressing
Usp2-45 with ENaC that was devoid of potential ubiquitylation
sites (lysine residues of the intracellular NH2-terminal domains
of all three subunits mutated to arginine) in Xenopus oocytes.
As expected for the case that Usp2-45 deubiquitylates ENaC
directly, this mutant channel was not activated in the presence
of Usp2-45 (Figure 3G).
To verify that the effect of Usp2-45 on ENaC function was not
an artifact that was due to the coexpression of two proteins in
Xenopus oocytes but also takes place with endogenous ENaC in
CCD cells, we addressed this question using the mouse CCD
cell line mpkCCDc14 (34). We actually first verified whether
Usp2-45 is expressed and regulated by aldosterone in these
cells. The relative expression of the two isoforms in mpkCCDc14
cells was similar to the observation made in microdissected
CNT/CCD with a 10-fold higher expression of the Usp2-45
Figure 4. Expression of endogenous and exogenous Usp2-45 in
mpkCCDcl4 cells. (A) Regulation of endogenous Usp2-45, Usp2-
69, and Sgk1 mRNA by aldosterone (106 M; see Materials and
Methods in online supplementary material and reference [35])
in mpkCCDc14 cells. Usp2-45 upregulation is slightly more
delayed than that of Sgk1. Unlike its isoform Usp2-45, Usp2-69
is not induced by aldosterone. Baseline mRNA abundance of
Usp2-45 was 10-fold higher than that of Usp2-69. Fold changes
of normalized means relative to -actin  SEM are given (n 
3). The isoform-specific real-time RT-PCR primers and probes
are shown in online supplementary material. (B) Baseline trans-
epithelial Iamil across mpkCCDcl4 cell monolayers that were
cultured on permeable supports is significantly increased in
cells that overexpressed Usp2-45 compared with vector-trans-
duced negative control cells (NC) and cells that were trans-
duced with protease-dead Usp2-45mut (). *P  0.05; n  9 to
12. Aldosterone (300 nM) given for 3 h increased Iamil similarly
in the monolayers that were made of the different mpkCCDcl4
cell populations ( ).
Figure 3. Usp2-45 increases amiloride-sensitive Na current (Iamil)
carried by coexpressed -ENaC. Original tracings are shown in
Supplementary Figure 3. (A) Summary of amiloride-sensitive
whole-cell currents at a holding potential of 100 mV. Coexpres-
sion of Usp2-45 or of XSgk1 increased the ENaC-mediated amilo-
ride-sensitive Iamil to a similar extent. These effects were not
additive. Data are means  SEM; n  23 to 27. **P  0.01; ***P 
0.001. (B through D) Characterization of Usp2-45 stimulatory ef-
fect on Iamil in Xenopus oocytes. (B) Cys67Ala protease-dead
Usp2-45 mutant (Usp2-45mut) does not stimulate XENaC current
Iamil at100 mV. Data are means SEM; n 12 to 15. **P 0.01.
(C) Another Usp (Usp15) does not stimulate XENaC-mediated
Iamil at100 mV. Data are means SEM; n 20 to 24. *P 0.05;
***P 0.001. (D) The Usp2-45 isoform does not stimulate XENaC-
mediated Iamil at 100 mV. Data are means  SEM; n  20 to 22.
***P  0.001. (E) Western blot made with lysate of control and
Usp2-45– and Usp2-69–expressing Xenopus oocytes and incu-
bated with a pan-Usp2 antibody shows specific bands that corre-
spond to each isoform, confirming that both were similarly ex-
pressed and that the lack of ENaC stimulation by Usp2-69 was not
due to a lack of expression of this isoform. (F) Effect of Usp2-45 on
ENaC-mediated Iamil is prevented bymutation of rENaC PYmotif
(rENaC-PYm). Iamil at100 mV is shown. Data are means SEM;
n  4 independent experiments with a total of 20 oocytes. *P 
0.05 using paired t test. (G) Effect of Usp2-45 on ENaC-mediated
Iamil is prevented by mutation of rENaC ubiquitylation site (ly-
sine-mutant rENaC-Km). Iamil at 100 mV is shown. Data are
means SEM; n 4 to 5 independent experiments with a total of
20 and 25 oocytes, respectively. *P 0.05; **P 0.01; ***P 0.001.
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mRNA. The time course of the regulation by aldosterone re-
vealed that only the Usp2-45 isoform was regulated (Figure
4A). To investigate the effect of Usp2-45 on the transepithelial
Na transport function, we expressed exogenous Usp2-45 as
well as mutant protease-dead Usp2-45 in mpkCCD cells by
retroviral transduction and verified by Western blot that the
expression levels were equal (Supplementary Figure 4). As
expected, when ENaC expression and activity were limited by
its ubiquitylation, expression of functional Usp2-45 increased
the baseline transepithelial amiloride-sensitive Na transport
(Figure 4B). In contrast, the expression of the protease-dead
mutant had no effect. The increase in Na transport that was
induced by aldosterone (300 M; see Materials and Methods in
the online supplementary material and reference [35]) that was
given for 3 h was not modified significantly by the expression
of wild-type and mutant Usp2-45, as expected considering that
short-term aldosterone prevents the Nedd4-2–mediated ubiq-
uitylation of ENaC by inducing Sgk1. These results that were
obtained in CCD cells confirm that Usp2-45, a ubiquitin-specific
protease that was identified because of its in vivo regulation by
aldosterone, also acts on endogenous ENaC in kidney tubule
cells.
To test directly the hypothesis that Usp2-45 counteracts the
effect of Nedd4-2 by deubiquitylating ENaC, we used Hek293
cells as an expression system. Coexpression of Nedd4-2 with
ENaC in Hek293 cells massively increased the ubiquitylated
form of the channel that was visualized with anti-ubiquitin
antibody on immunoprecipitates of - and -ENaC, thereby
confirming that ENaC was itself ubiquitylated (Figure 5A). The
impact of ubiquitylation on the total amount of ENaC was
demonstrated by the decreased amount of ENaC that was
visualized in the same samples with anti-ENaC antibody. Im-
portantly, Usp2-45 coexpression decreased the amount of ubiq-
uitylated ENaC and increased total ENaC, demonstrating that
Usp2-45 antagonizes the effect of Nedd4-2 by directly deubiq-
uitylating ENaC. The low level of ubiquitylated ENaC and the
substantial level of total ENaC that was observed with Usp2-45
coexpression were similar to those that were observed with
Nedd4-2cs, a catalytically inactive Nedd4-2 (Figure 5A).
Discussion
Early Aldosterone-Regulated Gene Products
The number of mRNA the level of which was changed two-
fold or more in mouse ASDN within 1 h after an aldosterone
injection is relatively low (22 mRNA). It is noteworthy that the
signal intensity of these regulated mRNA on control mice ar-
rays differs by more than two orders of magnitude, indicating
large differences in their absolute baseline expression levels
(see Supplementary Figure 1A). Not unexpected, the gene
product with the highest absolute expression level and the
second highest relative level of induction is Sgk1, the only early
aldosterone-regulated gene product of mammalian kidney that
has been identified earlier and shown to activate ENaC.
The gene product with the highest fractional increase (7.2-
fold in Affymetrix screen, 5.6-fold by real-time RT-PCR) is
Grem2 (protein related to DAN and cerebrus [PRDC]), an an-
tagonist of bone morphogenic proteins 2, 4, 6, and 7 (36). The
second upregulated gene product on the list is the already
mentioned Sgk1 that is followed by two members of the cAMP
response element binding (CREB) family of transcription fac-
tors, activating transcription factor 3 and cAMP responsive
element modulator.
Our list of early aldosterone-regulated mRNA also included
13 mRNA that are downregulated (Table 1). The known mRNA
with the highest fractional decrease (0.3-fold in Affymetrix
screen, 0.2-fold by real-time RT-PCR) encodes G0s2, a putative
G0/G1 switch gene the downregulation of which might pre-
vent proliferation and thus favor differentiation. It is interesting
Figure 5. Inverse regulation of ENaC ubiquitylation and ENaC
amount. (A) The ubiquitylated and the total amount of ENaC
expressed in Hek293 cells are visualized by Western blotting
(IB) of immunoprecipitated (IP) HA- and Flag-tagged - and
-rENaC subunits, respectively. The molecular weight of
marker proteins is indicated in kD. Coexpression of Nedd4-2
and not of ligase-inactive Nedd4-2 (Nedd4-2cs) increases the
ubiquitylation of both tested ENaC subunits, whereas it de-
creases their total amount. In the presence of Usp2-45, ENaC
ubiquitylation is decreased and the total subunit amount is
increased. (B) Schematic representation of the convergent effect
of Sgk1 and Usp2-45 that both decrease the amount of ubiqui-
tylated ENaC and thus increase the amount of intact channel.
The subcellular localization of these ubiquitylation/deubiqui-
tylation reactions has not yet been identified.
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that there are also two transport proteins among the downregu-
lated gene products, namely the polyspecific organic anion
transporter 3 (Slc22a8) and the colonic H,K-ATPase.
Role of Deubiquitylation in Aldosterone Action
The regulation of the gene products discussed in the previous
section seems to favor a decrease in proliferation of aldosterone
target cells and to foster their differentiation. In addition, our
screen identified with Sgk1 and Usp2-45 two aldosterone-in-
duced gene products that interfere with protein ubiquitylation.
As mentioned at the beginning of this article, Sgk1 was identi-
fied earlier as aldosterone-induced mRNA and protein, and its
effect on ENaC function has been shown to be mediated to a
large extent by its inhibitory action on the ubiquitylating en-
zyme Nedd4-2.
We have now indeed shown that the newly identified aldo-
sterone-induced Usp2-45 directly deubiquitylates ENaC in the
Hek273 cell expression system (Figure 5A). As expected, if the
ubiquitylation of ENaC would lead to ENaC degradation, then
the presence of Usp2-45 not only decreases the amount of
ubiquitylated ENaC but also increases the total amount of
ENaC. This biochemical evidence of ENaC deubiquitylation by
Usp2-45 is supported by functional experiments made in Xeno-
pus oocytes that show an increase in ENaC function that spe-
cifically is mediated by Usp2-45 and that depends on the in-
tegrity of its protease motif. Furthermore, we show both that
the disruption of ENaC PY motifs and the disruption of ENaC
lysine residues that potentially are targeted by Usp2-45 prevent
the action of Usp2-45 on ENaC function. These results also
strongly support the hypothesis that Usp2-45 acts on ubiquitin
moieties that are ligated onto ENaC by the ubiquitin ligase
Nedd4-2 (Figure 5B).
That a deubiquitylating enzyme that acts on ENaC is induced
by aldosterone strengthens the notion that ubiquitylation plays
a central role in the short-term regulation of ENaC. Although
deubiquitylation of target proteins has been described since the
early days of the ubiquitin system discovery (37), it has only
recently gained considerable interest as a regulatory mecha-
nism (for a review on deubiquitylation, see reference [29]). The
mouse as the human genome encodes approximately 100 pu-
tative deubiquitylating enzymes, the function of most of which
is not known. The Affymetrix screen that was presented in this
article revealed that approximately 26 of these Usp are ex-
pressed in the aldosterone target cells of the mouse kidney
tubule (present calls), but only Usp2-45 appeared in the list of
regulated RNA (Table 1). On the basis of our results, the deu-
biquitylation of ENaC by Usp2-45 seems to be specific for
Usp2-45, because none of the four other Usp that we tested in
expression systems activated and/or deubiquitylated this chan-
nel (Figure 3, C and D; unpublished results). As yet, actually
only a few examples of plasma membrane protein deubiquity-
lation have been published. One such example is the deubiq-
uitylation of yeast membrane permeases that leads to their
targeting to the vacuole (equivalent to the mammalian lyso-
some) by the ubiquitin-specific protease Doa4 (38). Another is
the deubiquitylation and stabilization of the EGF receptor by
the endosomal ubiquitin isopeptidases AMSH (associated mol-
ecule with the SHB domain of STAM) and UBPY (ubiquitin-
specific protease Y) (39,40).
The identification of ENaC as a target of Usp2-45 represents
the first report of a hormonally controlled channel-deubiquity-
lating mechanism. It is noteworthy to mention that this effect is
not selective for kidney tubule, because Usp2-45 is also ex-
pressed and regulated in distal colon, yet another target epi-
thelium of aldosterone (P.F. and F.V., unpublished observa-
tions). Previously published data on Usp2 suggest that its
isoform Usp2-69 is regulated by androgens in liver and pros-
tate, where it deubiquitylates and stabilizes fatty acid synthase
(33). Furthermore, Usp2 was shown to be regulated in bone by
parathyroid hormone (41), indicating that the Usp2 gene prod-
ucts mediate various important hormonally regulated func-
tions.
That the stimulatory action of Usp2-45 on ENaC depends on
previous ENaC ubiquitylation indicates, however, that Usp2-45
induction cannot explain the effect of aldosterone on Liddle-
type mutant ENaC (see the beginning of this article) (23,24).
Therefore, it is expected that still other aldosterone-induced
gene products, possibly also identified in our screen, act via
different pathways on ENaC expression and function.
Conclusion
Our list of early aldosterone-regulated gene products con-
tains two induced elements that interfere with the ubiquityla-
tion of ENaC. Besides Sgk1, we identified Usp2-45 that we
show to deubiquitylate ENaC in expression systems and thus
represents a first example of a deubiquitylating enzyme acting
on a channel.
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